APP下载

门诊两种降压药物短期降压疗效与不良反应的对比

2018-01-15邓霞刘鸿涛刘江红谢展雄王小康郑培丽

中国实用医药 2017年36期
关键词:厄贝沙坦氨氯地平不良反应

邓霞 刘鸿涛 刘江红 谢展雄 王小康 郑培丽

【摘要】 目的 探讨门诊两种降压药物短期降压疗效与不良反应的对比。方法 150例原发性高血压患者, 依据治疗药物的不同分为对照组和观察组, 每组75例。对照组采用氨氯地平治疗, 观察组采用厄贝沙坦治疗。比较两组患者的临床疗效、血压水平以及不良反应。结果 观察组治疗总有效率为84.00%, 略高于对照组的81.33%, 但差异无统计学意义(P>0.05)。两组患者治疗后的收缩压和舒张压均优于治疗前, 差异有统计学意义(P<0.05)。治疗后两组收缩压、舒张压水平比较差异无统计学意义(P>0.05)。观察组头晕头痛、嗜睡、乏力等不良反应发生率(9.33%)明显低于对照组(20.00%), 差异有统计学意义(P<0.05)。结论 厄贝沙坦与氨氯地平治疗原发性高血压效果相当, 不良反应较为轻微, 是临床理想的一线用药。

【关键词】 厄贝沙坦;氨氯地平;降压;不良反应

DOI:10.14163/j.cnki.11-5547/r.2017.36.054

Comparison of short-term antihypertensive efficacy and adverse reactions of two antihypertensive drugs in outpatient clinic DENG Xia, LIU Hong-tao, LIU Jiang-hong, et al. Department of Pharmacy, Shenzhen Longhua District Central Hospital, Shenzhen 518110, China

【Abstract】 Objective To compare the short-term antihypertensive efficacy and adverse reactions of two antihypertensive drugs in outpatient clinic. Methods A total of 150 essential hypertension patients were divided by different treatment drugs into control group and observation group, with 75 cases in each group. The control group was treated with amlodipine, and the observation group was treated with irbesartan. Comparison were made on clinical efficacy, blood pressure level and adverse reactions between two groups. Results The observation group had little higher total treatment effective rate as 84.00% than 81.33% in the control group, but the difference was not statistically significant (P>0.05). Both groups had better systolic blood pressure and diastolic blood pressure than before treatment, and their difference was statistically significant (P<0.05). Both groups had no statistically significant difference in systolic blood pressure and diastolic blood pressure after treatment (P>0.05). The observation group had obviously lower incidence of adverse reactions of dizziness headache, drowsiness, fatigue (9.33%) than the control group (20.00%), and the difference was statistically significant (P<0.05). Conclusion Irbesartan and amlodipine provides equal effect in treating essential hypertension patients with slight adverse reactions, and it is ideal first-line medication in clinic.

【Key words】 Irbesartan; Amlodipine; Antihypertensive; Adverse reactions

原發性高血压是临床常见的心血管疾病, 尤其好发于中老年人, 且随着年龄的增高发病率明显上升, 其对心、脑、肾等靶器官均有明显损害, 能够并发多种心脑血管、肾脏、眼部并发症, 严重威胁患者的健康甚至造成死亡。因此, 如何有效防治高血压, 降低高血压对全身各脏器的损害是临床探讨的热点之一。目前, 临床可供选择的降压药种类繁多, 作用机制不一, 患者对药物的敏感性也有明显差异, 给临床的合理用药带来一定难度[1]。本研究分析厄贝沙坦与氨氯地平两种门诊常用降压药的短期疗效和不良反应, 现汇报如下。

1 资料与方法

1. 1 一般资料 选取2016年4月~2017年4月在本院心内科收治的150例原发性高血压患者, 依据治疗药物的不同分为观察组和对照组, 每组75例。观察组男36例, 女39例,endprint

猜你喜欢

厄贝沙坦氨氯地平不良反应
缬沙坦联合氨氯地平片在老年顽固性高血压病人中的临床应用
缬沙坦氨氯地平与氨氯地平治疗高血压的应用效果分析
氨氯地平联合阿托伐他汀钙片治疗高血压合并冠心病的疗效观察
氨氯地平联合氯沙坦治疗高血压的临床疗效观察
厄贝沙坦等治疗老年糖尿病高血压合并高尿酸血症患者的效果
厄贝沙坦联合乐卡地平治疗老年轻中度高血压患者的疗效评价
高原地区高血压心肌纤维化的临床及干预研究
活血降糖胶囊与厄贝沙坦联用治疗早期2型糖尿病肾病的临床分析
综合护理干预对首次机采血小板献血者持续献血应用效果分析
骨瓜提取物的不良反应分析